Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB2) ligand designed for PET studies.
| Image |  |
|---|---|
| Description | scientific article published on 30 January 2018 |
| Author/s |
author: Dirk Schepmann |
| Publication date | January 31, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |